发明名称 |
PHARMACEUTICAL COMPOSITION FOR ENZYME REPLACEMENT THERAPY |
摘要 |
<p>The present invention provides a pharmaceutical composition comprising a protein having ±-galactosidase activity for treating Fabry disease, which causes no allergic side effect, which is highly stable in blood (plasma) and which can readily be taken up by a cell of an affected organ. The pharmaceutical composition for treating Fabry disease of the invention comprises, for example, a protein which acquires an ±-galactosidase activity through alteration of the structure of the active site of wild-type human ±-N-acetylgalactosaminidase.</p> |
申请公布号 |
EP2166093(A1) |
申请公布日期 |
2010.03.24 |
申请号 |
EP20080753111 |
申请日期 |
2008.05.19 |
申请人 |
TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEARCH;ALTIF LABORATORIES, INC. |
发明人 |
SAKURABA, HITOSHI;TAJIMA, YOUICHI;KAWASHIMA, IKUO;AIKAWA, SEIICHI;AIKAWA, FUMIKO |
分类号 |
C12N15/09;A61K38/43;A61K48/00;A61P3/00;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N9/40 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|